Acute leukaemia: making sense of a complex blood cancer, British journal of nursing, vol.21, issue.2, pp.78-83, 2012. ,
Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia, Leukemia, vol.26, issue.10, pp.2176-2185, 2012. ,
Tumor-stroma interactions in tumorigenesis: lessons from stem cell biology, Frontiers in bioscience, vol.4, pp.1871-1887, 2012. ,
Tumor microenvironment: a main actor in the metastasis process, Clin Exp Metastasis, vol.29, issue.4, pp.381-395, 2012. ,
Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis?, Oncogene, vol.23, issue.2, pp.317-329, 2004. ,
The ADAMs: signalling scissors in the tumour microenvironment, Nat Rev Cancer, vol.8, issue.12, pp.929-941, 2008. ,
Roles of metalloproteases in metastatic niche, Curr Mol Med, vol.11, issue.8, pp.609-622, 2011. ,
Matrix metalloproteinases: changing roles in tumor progression and metastasis. The American journal of pathology, vol.181, pp.1895-1899, 2012. ,
ADAMs in cancer cell proliferation and progression, Cancer Sci, vol.98, issue.5, pp.621-628, 2007. ,
ADAM17 as a therapeutic target in multiple diseases, Curr Pharm Des, vol.15, issue.20, pp.2319-2335, 2009. ,
Physiology and pathophysiology of matrix metalloproteases, Amino Acids, vol.41, issue.2, pp.271-290, 2011. ,
Matrix metalloproteinases: regulators of the tumor microenvironment, Cell, vol.141, issue.1, pp.52-67, 2010. ,
New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression, Biochim Biophys Acta-Reviews on Cancer, vol.1825, issue.1, pp.29-36, 2012. ,
Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects, Med Res Rev, vol.26, issue.1, pp.88-130, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00323888
The moonlighting enzyme CD13: old and new functions to target, Trends Mol Med, vol.14, issue.8, p.361, 2008. ,
Transmembrane proteases as disease markers and targets for therapy, J Biol Regul Homeost Agents, vol.15, issue.2, pp.130-139, 2001. ,
Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer, J Clin Oncol, vol.27, issue.31, pp.5287-5297, 2009. ,
Aminopeptidase N (CD13) as a target for cancer chemotherapy, Cancer Sci, vol.102, issue.3, pp.501-508, 2011. ,
Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview, Mutat Res, vol.753, issue.1, pp.7-23, 2013. ,
Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells, Br J Haematol, vol.105, issue.2, pp.402-411, 1999. ,
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia, Crit Rev Oncol Hematol, vol.50, issue.2, pp.87-100, 2004. ,
Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes, Clin Cancer Res, vol.5, issue.5, pp.1115-1124, 1999. ,
Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation, Eur J Haematol, vol.84, issue.3, pp.239-251, 2009. ,
Mechanistic insights into the antileukemic activity of hyperforin, Curr Cancer Drug Targets, vol.13, issue.1, pp.1-10, 2013. ,
Role of leukemia cell invadosome in extramedullary infiltration, Blood, vol.114, issue.14, pp.3008-3017, 2009. ,
Marrow matrix metalloproteinases (MMPs) and tissue inhibitors of MMP in acute leukaemia: potential role of MMP-9 as a surrogate marker to monitor leukaemic status in patients with acute myelogenous leukaemia, Br J Haematol, vol.117, issue.4, pp.835-841, 2002. ,
Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia, Blood, vol.106, issue.13, pp.4086-4092, 2005. ,
Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells, Faseb J, vol.25, issue.8, pp.2831-2842, 2011. ,
Differential regulation of tumor necrosis factor-alpha-converting enzyme and angiotensin-converting enzyme by type I and II interferons in human normal and leukemic myeloid cells, Oncogene, vol.26, issue.1, pp.102-110, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00126528
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL, PloS one, vol.7, issue.2, p.31594, 2012. ,
Expression of myeloid differentiation antigens on normal and malignant myeloid cells, J Clin Invest, vol.68, issue.4, pp.932-941, 1981. ,
CD-13 ('gp150'; aminopeptidase-N): coexpression on endothelial and haemopoietic cells with conservation of functional activity, Immunol Cell Biol, vol.69, pp.253-260, 1991. ,
Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33, Br J Haematol, vol.69, issue.2, pp.163-171, 1988. ,
Pitstop 2 is a potent inhibitor of clathrin-independent endocytosis, PloS one, vol.7, issue.9, p.45799, 2012. ,
Prognostic relevance of circulating matrix metalloproteinase-2 in acute myeloid leukaemia patients, Hematological oncology, vol.25, issue.3, pp.121-126, 2007. ,
The regulation of inflammation by interferons and their STATs, Jak-Stat, vol.2, issue.1, p.23820, 2013. ,
Interferon-gamma production by neutrophils during bacterial pneumonia in mice, Am J Respir Crit Care Med, vol.183, issue.10, pp.1391-1401, 2011. ,
Internalization of human macrophage surface antigens induced by monoclonal antibodies, J Immunol Methods, vol.188, issue.1, pp.147-154, 1995. ,
Endocytosis unplugged: multiple ways to enter the cell, Cell research, vol.20, issue.3, pp.256-275, 2010. ,
Protein targeting by tyrosine-and di-leucine-based signals: evidence for distinct saturable components, The Journal of cell biology, vol.135, issue.2, pp.341-354, 1996. ,
Stimulation-induced downregulation of tumor necrosis factor-alpha converting www.impactjournals.com/oncotarget enzyme, J Biol Chem, vol.275, pp.14598-14607, 2000. ,
Cell surface colony-stimulating factor 1 can be cleaved by TNF-alpha converting enzyme or endocytosed in a clathrin-dependent manner, J Immunol, vol.179, issue.10, pp.6715-6724, 2007. ,
The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways, J Biol Chem, vol.282, issue.16, pp.12341-12352, 2007. ,
Plasma membrane microdomains regulate TACE-dependent TNFR1 shedding in human endothelial cells, Journal of cellular and molecular medicine, vol.16, issue.3, pp.627-636, 2012. ,
RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer, Cancer Metastasis Rev, vol.26, issue.3-4, pp.675-683, 2007. ,
RECK Inhibits Stemness Gene Expression and Tumorigenicity of Gastric Cancer Cells by Suppressing ADAM-Mediated Notch1 Activation, J Cell Physiol, vol.229, issue.2, pp.191-201, 2014. ,
Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis, Ann Rheum Dis, vol.64, issue.3, pp.368-374, 2005. ,
Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis. The American journal of pathology, vol.167, pp.1061-1069, 2005. ,
RECKing MMP function: implications for cancer development, Trends in cell biology, vol.12, issue.5, pp.209-211, 2002. ,
Lipids as targeting signals: lipid rafts and intracellular trafficking, Traffic, vol.5, issue.4, pp.247-254, 2004. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00167026
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO, Proc Natl Acad Sci, vol.98, issue.21, pp.12138-12143, 2001. ,
The shedding activity of ADAM17 is sequestered in lipid rafts, Exp Cell Res, vol.312, issue.20, pp.3969-3980, 2006. ,
Immunoisolation and partial characterization of endothelial plasmalemmal vesicles (caveolae), Molecular biology of the cell, vol.8, issue.4, pp.595-605, 1997. ,
Depletion of cellular cholesterol and lipid rafts increases shedding of CD30, J Immunol, vol.172, issue.7, pp.4324-4331, 2004. ,
ErbB-4 and TNF-alpha converting enzyme localization to membrane microdomains, Biochem Biophys Res Commun, vol.350, issue.3, pp.629-633, 2006. ,
HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases, Mol Cell, vol.49, issue.4, pp.668-679, 2013. ,
Aminopeptidase N/CD13 is associated with raft membrane microdomains in monocytes, Biochem Biophys Res Commun, vol.269, issue.1, pp.143-148, 2000. ,
Ezetimib influences the expression of raftassociated antigens in human monocytes, Cytometry A, vol.69, issue.3, pp.206-208, 2006. ,
The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer, Semin Cell Dev Biol, vol.20, issue.2, pp.164-174, 2009. ,
Crossing the endothelial barrier during metastasis, Nat Rev Cancer, vol.13, issue.12, pp.858-870, 2013. ,
The role of ADAM-mediated shedding in vascular biology, European journal of cell biology, vol.91, issue.6-7, pp.472-485, 2012. ,
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17), Blood, vol.121, issue.18, pp.3599-3608, 2013. ,
ADAM17-Mediated Shedding of FcgammaRIIIA on Human NK Cells: Identification of the Cleavage Site and Relationship with Activation, J Immunol, vol.192, issue.2, pp.741-751, 2014. ,
Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition, Clin Cancer Res, vol.19, issue.14, pp.3844-3855, 2013. ,
NB4, a maturation inducible cell www.impactjournals.com/oncotarget line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3), Blood, vol.77, issue.5, pp.1080-1086, 1991. ,
Inactivation of interleukin-6 in vitro by monoblastic U937 cell plasma membranes involves both protease and peptidyl-transferase activities, Eur J Biochem, vol.215, issue.3, pp.825-831, 1993. ,
Upregulation of CD38 gene expression in leukemic B cells by interferon types I and II, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, vol.19, issue.9, pp.1059-1066, 1999. ,
Human B lymphocytes synthesize the 92-kDa gelatinase, matrix metalloproteinase-9, J Biol Chem, vol.273, issue.32, pp.20677-20684, 1998. ,
Review: the role of membrane peptidases in immune functions, Adv Exp Med Biol, vol.477, pp.1-24, 2000. ,
Expression of tumor necrosis factor-alpha--converting enzyme and tumor necrosis factor-alpha in human myocarditis, J Am Coll Cardiol, vol.36, issue.4, pp.1288-1294, 2000. ,
Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons, Leukemia, vol.16, issue.5, pp.791-798, 2002. ,
Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas, Int J Cancer, vol.106, issue.6, pp.848-855, 2003. ,
IFNbeta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7, Oncogene, vol.19, issue.30, pp.3372-3383, 2000. ,